Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Shields

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Science Translational Medicine|August 10, 2022
Adenoviral-based vaccine promotes neoantigen-specific CD8<sup>+</sup> T cell stemness and tumor rejectionAnna Morena D'Alise, Nadia Brasu, Carlo De Intinis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal CancerRyuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2020
The impact of ARID1A mutation on molecular characteristics in colorectal cancerRyuma Tokunaga, Joanne Xiu, Richard M Goldberg, et al.
Oncogene|June 24, 2021
Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancerJingyuan Wang, Joanne Xiu, Yasmine Baca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2021
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and OxaliplatinElisa Fontana, Jeff Meyers, Alberto Sobrero, et al.
JAMA Oncology|January 26, 2023
Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon CancerEn Cheng, Qian Shi, Anthony F Shields, et al.
Journal of Surgical Oncology|March 14, 2020
Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinomaMatthew K Stein, Forrest W Williard, Joanne Xiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic AdenocarcinomaPhilip A Philip, Ibrahim Azar, Joanne Xiu, et al.
JAMA Oncology|December 4, 2025
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical TrialGeorge Q Zhang, Jeffrey A Meyerhardt, Qian Shi, et al.
Journal of Surgical Oncology|January 11, 2023
Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysisAndrew M Fleming, Benjamin W Deschner, Forrest W Williard, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Science Translational Medicine|August 10, 2022
Adenoviral-based vaccine promotes neoantigen-specific CD8<sup>+</sup> T cell stemness and tumor rejectionAnna Morena D'Alise, Nadia Brasu, Carlo De Intinis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal CancerRyuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2020
The impact of ARID1A mutation on molecular characteristics in colorectal cancerRyuma Tokunaga, Joanne Xiu, Richard M Goldberg, et al.
Oncogene|June 24, 2021
Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancerJingyuan Wang, Joanne Xiu, Yasmine Baca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2021
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and OxaliplatinElisa Fontana, Jeff Meyers, Alberto Sobrero, et al.
JAMA Oncology|January 26, 2023
Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon CancerEn Cheng, Qian Shi, Anthony F Shields, et al.
Journal of Surgical Oncology|March 14, 2020
Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinomaMatthew K Stein, Forrest W Williard, Joanne Xiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic AdenocarcinomaPhilip A Philip, Ibrahim Azar, Joanne Xiu, et al.
JAMA Oncology|December 4, 2025
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical TrialGeorge Q Zhang, Jeffrey A Meyerhardt, Qian Shi, et al.
Journal of Surgical Oncology|January 11, 2023
Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysisAndrew M Fleming, Benjamin W Deschner, Forrest W Williard, et al.
Pageof 19